THE ASCENT OF ANTIBIOTICS: RESISTANT SUPERBUGS
International Journal of Progressive Research in Engineering Management and Science · 24.06.2026
DOI: 10.58257/ijprems53980 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Progressive Research in Engineering Management and Science, online erschienen am 24.06.2026.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) has emerged as a defining challenge in modern medicine, threatening to reverse decades of therapeutic progress.This review synthesises current knowledge on the emergence and global spread of antibiotic-resistant superbugs, with emphasis on epidemiology, molecular resistance mechanisms, and clinical implications.Bacterial adaptability-driven by mutation, horizontal gene transfer, and selective pressure-enables rapid evolution of resistance across multiple drug classes.The pharmacological basis of major antibiotic groups is critically evaluated, including mechanisms of action, resistance pathways, and associated adverse effects.Specific antimicrobial agents are correlated with clinically relevant target organisms, highlighting evidence-based treatment strategies for MDR infections.Emerging approaches-bacteriophage therapy, CRISPR-mediated gene editing, and novel synthetic antibiotics-are discussed in the context of the current antibiotic development stagnation.Addressing AMR requires scientific innovation, coordinated global stewardship, policy reform, and rational antibiotic use.
Zitieren
APA
(2026). THE ASCENT OF ANTIBIOTICS: RESISTANT SUPERBUGS. International Journal of Progressive Research in Engineering Management and Science. https://doi.org/10.58257/ijprems53980
Vancouver
THE ASCENT OF ANTIBIOTICS: RESISTANT SUPERBUGS. International Journal of Progressive Research in Engineering Management and Science. 2026. doi:10.58257/ijprems53980
BibTeX
@article{euvimed2026,
title = {THE ASCENT OF ANTIBIOTICS: RESISTANT SUPERBUGS},
journal = {International Journal of Progressive Research in Engineering Management and Science},
year = {2026},
doi = {10.58257/ijprems53980}
}
EUVIMED